Now report generation is in the hands of users for faster, easier
analysis, and greater insight
BALTIMORE--(BUSINESS WIRE)--
Master data management reporting for business users is now available in
Veeva Network, Veeva Systems announced today at the 2015 Prescription
Drug Marketing Association (PDMA) Sharing Conference.
Veeva Network Reporting addresses the need for commercial teams to
proactively manage the quality of master data in mission critical areas
such as sales planning, new product launches, and stewardship
operations. Typically, business users have to request reports from the
IT department. IT, in turn, extracts the relevant data, loads it into a
data warehouse, and runs reports using an analytics tool. This process
may take days or weeks, and limits data visibility.
In contrast, Veeva Network Reporting empowers commercial operations,
data stewards, and other business users to quickly gain insights into
master data, without relying on IT. The new reporting capability
benefits both business users seeking to optimize data for strategic
commercial uses, and data stewards looking to diagnose the root cause of
errors and improve data quality. Veeva Network reporting saves time and
IT resources, while enhancing business agility.
“Visibility into master data is critical as it can impact both speed to
market and customer engagement,” said Eric Newmark, program director,
IDC Health Insights. “The industry has a strong need for capabilities
that give business users unencumbered access and reporting so they can
rectify errors before the data is used in sales, marketing, or medical
outreach to customers.”
Growing numbers of life sciences companies are leveraging Veeva Network
to manage their master data. It is enabling more tailored and compliant
customer engagements by delivering a trusted single view of healthcare
professionals and healthcare organizations.
“Veeva Network is an enterprise-class master data management application
that is specifically tailored to meet the unique needs of life sciences
business users,” said Dan Goldsmith, Veeva’s chief strategy officer.
“Veeva Network’s built-in reporting capabilities empower commercial
teams to deeply understand their master data, and to rapidly resolve
problems that could prevent business critical projects from delivering
maximal benefit.”
To learn more, join a discussion with Veeva Network customer Medac
Pharma on Tuesday, Sept. 29, at the PDMA event. Glenn Tate, senior
director of IT, will describe how Medac successfully leveraged Veeva
Network to help launch its first product, Rasuvo® (methotrexate
injection). Visitors can also stop by booth #111/113 to see a
demonstration of Veeva Network’s new reporting capability.
Additional Information
For more on Veeva Network, visit: veeva.com/mdm
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in
cloud-based software for the global life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva has more
than 300 customers, ranging from the world's largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices in Europe, Asia, and Latin America. For
more information, visit www.veeva.com.
Forward-looking Statements
This release contains
forward-looking statements, including the market demand for and
acceptance of Veeva’s products and services, the results from use of
Veeva’s products and services, and general business conditions,
particularly in the life sciences industry. Any forward-looking
statements contained in this press release are based upon Veeva’s
historical performance and its current plans, estimates, and
expectations, and are not a representation that such plans, estimates,
or expectations will be achieved. These forward-looking statements
represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-Q for the period ended July 31, 2015. This is available on the
company’s website at http://www.veeva.com
under the Investors section and on the SEC’s website at www.sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150928005386/en/
Source: Veeva Systems Inc.